Lecithinized superoxide dismutase treatment improves steroid-refractory interstitial pneumonia

Respirology

Volumn 15, Issue 8, 2010, Pages 1261-1265

  Kawashima, Tatsuo ^a   Wakabayashi, Toru ^a   Kuroda, Toshihisa ^a   Nishide, Toshio ^b   Matsuzawa, Yasuo ^a   Shirai, Kohji ^a  

^a TOHO UNIVERSITY   (Japan)

^b Nishide Internal Medicine   (Japan)

Author keywords

Amyopathic dermatomyositis; Interstitial pneumonia; Steroid refractory; Superoxide; Superoxide dismutase

Indexed keywords

CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN; GLYCOPROTEIN; KREBS VON DEN LUNGEN 6 PROTEIN; METHYLPREDNISOLONE; PREDNISOLONE; SUPEROXIDE DISMUTASE; TACROLIMUS; UNCLASSIFIED DRUG;

ADD ON THERAPY; ADULT; AMYOPATHIC DERMATOMYOSITIS; ARTICLE; CASE REPORT; CORTICOSTEROID THERAPY; CYTAPHERESIS; DERMATOMYOSITIS; DISEASE ASSOCIATION; DISEASE COURSE; DRUG DOSE REDUCTION; DRUG MEGADOSE; DRUG PULSE THERAPY; DYSPNEA; EXERCISE TOLERANCE; HIGH RESOLUTION COMPUTER TOMOGRAPHY; HUMAN; HUMAN TISSUE; IDIOPATHIC DISEASE; IMMUNOSUPPRESSIVE TREATMENT; INTERSTITIAL PNEUMONIA; LEUKOCYTAPHERESIS; LUNG BIOPSY; LUNG FUNCTION; LUNG FUNCTION TEST; MALE; MULTIPLE CYCLE TREATMENT; PRIORITY JOURNAL; TRANSBRONCHIAL BIOPSY; TREATMENT OUTCOME; TREATMENT RESPONSE;

ADRENAL CORTEX HORMONES; CYCLOSPORINE; DERMATOMYOSITIS; EXERCISE TOLERANCE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LUNG DISEASES, INTERSTITIAL; MALE; METHYLPREDNISOLONE; MIDDLE AGED; MUCIN-1; PHOSPHATIDYLCHOLINES; PREDNISOLONE; PULMONARY FIBROSIS; RESPIRATORY FUNCTION TESTS; SUPEROXIDE DISMUTASE; TACROLIMUS; TREATMENT OUTCOME;

EID: 78349291889     PISSN: 13237799     EISSN: 14401843     Source Type: Journal    
DOI: 10.1111/j.1440-1843.2010.01851.x     Document Type: Article

References (13)

1. International Consensus Statement. Idiopathic pulmonary fibrosis: diagnosis and treatment. Am. J. Respir. Crit. Care Med. 2000; 161: 646-64.
2. Kuwano K, Nakashima N, Inoshima I, et al. Oxidative stress in lung epithelial cells from patients with idiopathic interstitial pneumonias. Eur. Respir. J. 2003; 21: 232-40.
3. Reynolds HY, Fulmer JD, Kazmierowski JA, et al. Analysis of cellular and protein content of broncho-alveolar lavage fluid from patients with idiopathic pulmonary fibrosis and chronic hypersensitivity pneumonitis. J. Clin. Invest. 1977; 59: 165-75.
4. Nathan CF, Brukner LH, Silverstein SC, et al. Extracellular cytolysis by activated macrophages and granulocytes. I. Pharmacologic triggering of effector cells and the release of hydrogen peroxide. J. Exp. Med. 1979; 149: 84-99.
5. Nathan CF, Brukner LH, Silverstein SC, et al. Extracellular cytolysis by activated macrophages and granulocytes. II. Hydrogen peroxide as a mediator of cytotoxicity. J. Exp. Med. 1979; 149: 100-13.
6. Mizushima Y, Igarashi R,. Studies on polypeptide drug delivery system: tissue distribution of immunoglobulin G conjugated with lecithin. J. Control. Release 1991; 17: 99-104.
7. Igarashi R, Hoshino J, Takenaga M, et al. Lecithinization of superoxide dismutase potentiates its protective effects against Forssman antiserum-induced elevation in guinea pig airway resistance. J. Pharmacol. Exp. Ther. 1992; 262: 1214-19.
8. Yamazaki C, Hoshino J, Hori Y, et al. Effect of lecithinized-superoxide dismutase on the interstitial pneumonia model induced by bleomycin in mice. Jpn. J. Pharmacol. 1997; 75: 97-100. (Pubitemid 27462580)
9. Suzuki Y, Matsumoto T, Okamoto S, et al. A lecithinized superoxide dismutase (PC-SOD) improves ulcerative colitis. Colorectal Dis. 2008; 10: 931-4.
10. Kohno K, Akiyama M, Kyoizumi S, et al. New serum indicator of interstitial pneumonitis activity. Sialylated carbohydrate antigen KL-6. Chest 1989; 96: 68-73.
11. Hirasawa Y, Kohno N, Yokoyama A, et al. KL-6, a human MUC1 mucin, is chemotactic for human fibroblasts. Am. J. Respir. Cell Mol. Biol. 1997; 17: 501-7.
12. Lynch DA, Travis WD, Muller NL, et al. Idiopathic interstitial pneumonias: CT features. Radiology 2005; 236: 10-21.
13. Rabbani ZN, Anscher MS, Folz RJ, et al. Overexpression of extracellular superoxide dismutase reduces acute radiation induced lung toxicity. BMC Cancer 2005; 5: 59.